drugset / Trial / NCT00119756

A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia

NCT00119756

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and tolerability of intramuscular injections (to the buttocks or to the shoulders) of paliperidone palmitate in patients with schizophrenia.

Timeline

Start
2005-06
Primary completion
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject paliperidone palmitate Unknown 50 mg Intramuscular
Subject paliperidone palmitate Unknown 75 mg Intramuscular
Subject paliperidone palmitate Unknown 100 mg Intramuscular

Indications